Figure 1

Figure 2

Figure 3

Figure 4

Results from testing the hypothesis
| Hypotheses | Based on AAR(0) result | Based on CAAR result |
|---|---|---|
| H1P: Public disclosure of an arrangement conclusion in restructuring proceedings results in above-average stock return rates (Event No. 1). | Confirmation of H1P. We observe positive and statistically significant (a = 0.05) abnormal rate of return on the event day. | There is no basis for considering the H1P hypothesis valid due to not observing any (positive or negative) statistically significant abnormal rates of return for ALL sample. The CAAR value is negative, but not statistically significant. |
| H2P: Public disclosure of the court approval of an arrangement in restructuring proceedings results in above-average stock return rates (Event No. 2). | There is no basis for considering the H2P hypothesis valid due to not observing any (positive or negative) statistically significant abnormal rates of return for ALL sample. | There is no basis for considering the H2P hypothesis valid due to not observing any (positive or negative) statistically significant abnormal rates of return for ALL sample. The CAAR value is negative, but not statistically significant. |
| H3P: Public disclosure of an arrangement approval in restructuring proceedings becoming final results in above-average stock return rates (Event No. 3). | Confirmation of H3P. We observe positive and statistically significant (a = 0.01) abnormal rate of return on the event day. | Confirmation of H3P. We observe positive and statistically significant (a = 0.01) abnormal rate of return on the event window. |
Descriptive statistics for the number of days from the public disclosure of information about the studied events
| No. | Descriptive statistics | Situation 1 | Situation 2 | Situation 3 |
|---|---|---|---|---|
| 1 | Arithmetic mean | 41.3 | 132.2 | 90.9 |
| 2 | Median | 23.0 | 100.5 | 76.0 |
| 3 | Mode | 14.0 | 56.0 | 41.0 |
| 4 | Standard deviation | 47.4 | 90.2 | 61.6 |
| 5 | Kurtosis | 7.9 | 0.3 | 0.4 |
| 6 | Skewness | 2.8 | 1.1 | 1.0 |
| 7 | Range | 198.0 | 319.0 | 238.0 |
| 8 | Minimum | 12.0 | 27.0 | 13.0 |
| 9 | Maximum | 210.0 | 346.0 | 251.0 |
j_ijme-2022-0014_apptab_001
| No. | Company name | Creditors’ approval of the arrangement (Event No. 1) | Court approval of the arrangement (Event No. 2) | Court validation of the arrangement (Event No. 3) | Start of the estimation window | End of the estimation window |
|---|---|---|---|---|---|---|
| 1 | ACTION | January 10, 2020 | August 7, 2020 | December 17, 2020 | August 6, 2019 | January 2, 2020 |
| 2 | AEDES | February 23, 2017 | April 19, 2017 | September 26, 2016 | February 16, 2017 | |
| 3 | ALUMAST | June 22, 2011 | July 5, 2011 | July 26, 2011 | January 24, 2011 | June 15, 2011 |
| 4 | ATONHT | February 28, 2020 | September 14, 2020 | February 8, 2021 | September 25, 2019 | February 21, 2020 |
| 5 | BIOMEDLUB | June 13, 2016 | July 12, 2016 | September 30, 2016 | January 13, 2016 | June 6, 2016 |
| 6 | BUMECH | July 12, 2018 | September 19, 2018 | March 18, 2019 | February 9, 2018 | July 5, 2018 |
| 7 | DREWEX | October 7, 2014 | October 28, 2014 | January 12, 2015 | May 12, 2014 | September 30, 2014 |
| 8 | DUDA | July 27, 2009 | September 15, 2009 | September 28, 2009 | February 25, 2009 | July 20, 2009 |
| 9 | ELEKTROEX | December 5, 2005 | December 21, 2005 | August 1, 2006 | July 7, 2005 | November 28, 2005 |
| 10 | IDEON | August 8, 2013 | September 4, 2013 | October 15, 2013 | March 7, 2013 | August 1, 2013 |
| 11 | IDMSA | September 24, 2019 | October 17, 2019 | April 6, 2020 | April 25, 2019 | September 17, 2019 |
| 12 | IMAGIS | January 19, 2017 | March 28, 2017 | June 14, 2017 | August 22, 2016 | January 12, 2017 |
| 13 | INTAKUS | June 3, 2013 | June 21, 2013 | August 21, 2013 | December 27, 2012 | May 24, 2013 |
| 14 | INTERBUD | October 2, 2019 | November 14, 2019 | February 21, 2020 | May 7, 2019 | September 25, 2019 |
| 15 | INVICO | June 24, 2016 | July 14, 2016 | October 13, 2016 | January 26, 2016 | June 17, 2016 |
| 16 | MARKA | June 13, 2017 | July 18, 2017 | September 26, 2017 | January 12, 2017 | June 6, 2017 |
| 17 | MIRACULUM | May 23, 2011 | June 6, 2011 | July 18, 2011 | December 21, 2010 | May 16, 2011 |
| 18 | MONNARI | September 30, 2010 | October 22, 2010 | November 9, 2010 | May 6, 2010 | September 23, 2010 |
| 19 | ODLEWNIE | May 4, 2010 | May 18, 2010 | May 31, 2010 | December 1, 2009 | April 26, 2010 |
| 20 | PBG | August 25, 2015 | October 9, 2015 | June 16, 2016 | March 26, 2015 | August 18, 2015 |
| 21 | RAFAKO | December 11, 2020 | January 13, 2021 | June 29, 2021 | July 17, 2020 | December 4, 2020 |
| 22 | REGNON | December 2, 2011 | December 14, 2011 | February 20, 2012 | July 6, 2011 | November 25, 2011 |
| 23 | REGNON | May 25, 2018 | June 7, 2018 | August 3, 2018 | December 20, 2017 | May 18, 2018 |
| 24 | RUCHCHORZ | December 1, 2017 | December 14, 2017 | April 9, 2018 | July 6, 2017 | November 24, 2017 |
| 25 | SATIS | December 3, 2019 | March 10, 2020 | August 3, 2020 | July 5, 2019 | November 26, 2019 |
| 26 | SFINKS | February 11, 2021 | March 10, 2021 | September 10, 2020 | February 4, 2021 | |
| 27 | TXM | May 25, 2020 | June 17, 2020 | August 31, 2020 | December 18, 2019 | May 18, 2020 |
| 28 | VISTAL | July 11, 2019 | July 25, 2019 | September 4, 2019 | February 8, 2019 | July 4, 2019 |
| 29 | VIVID | September 16, 2020 | November 5, 2020 | December 23, 2020 | April 21, 2020 | September 9, 2020 |
| 30 | WILBO | October 29, 2014 | November 12, 2014 | January 27, 2015 | June 3, 2014 | October 22, 2014 |
| 31 | WORKSERV | December 28, 2020 | January 12, 2021 | February 22, 2021 | July 30, 2020 | December 17, 2020 |
| 32 | ZREMB | November 15, 2018 | December 5, 2018 | February 26, 2019 | July 19, 2018 | November 7, 2018 |
| 33 | BUDOPOL | December 19, 2015 | February 11, 2016 | May 25, 2016 | For these companies, a lack of price changes within the adopted estimation window was observed, and thus they were excluded from the research sample. | |
| 34 | ESTAR | March 25, 2013 | ||||
| 35 | GETBACK | January 25, 2019 | June 6, 2019 | February 26, 2020 | ||
| 36 | UNIFIED | February 21, 2020 | May 14, 2020 | |||
| 37 | VERTE | November 15, 2017 | January 19, 2018 | |||
Event analysis results, including AAR values
| Event No. | Grouping variable/test statistics | AAR (−1) | AAR (0) | AAR (1) | AAR (2) | AAR (3) | AAR (4) |
|---|---|---|---|---|---|---|---|
| 1 | ALL (N = 32) AAR | −2.4% | 2.0% | 2.5% | −0.4% | −2.2% | −2.9% |
| Adjusted Patell Z | −2.066 | 1.991 | 1.680 | −1.894 | −2.311 | −0.992 | |
| Adjusted Patell Z p-value | 0.039** | 0.047** | 0.093* | 0.058* | 0.021** | 0.321 | |
| IN (N = 24) AAR | −2.2% | 2.0% | 4.5% | 0.2% | −1.4% | −3.3% | |
| Adjusted Patell Z | −1.515 | 1.670 | 2.768 | −1.615 | −1.535 | −0.772 | |
| Adjusted Patell Z p-value | 0.130 | 0.095* | 0.006*** | 0.106 | 0.125 | 0.440 | |
| OUTSIDE (N = 8) AAR | −3.0% | 1.9% | −3.5% | −2.2% | −4.6% | −1.7% | |
| Adjusted Patell Z | −1.513 | 1.094 | −1.438 | −0.994 | −1.970 | −0.649 | |
| Adjusted Patell Z p-value | 0.130 | 0.274 | 0.151 | 0.320 | 0.049** | 0.516 | |
| 2 | ALL (N = 32) AAR | −0.6% | 0.3% | −3.6% | 1.5% | 0.1% | −1.9% |
| Adjusted Patell Z | −0.575 | 0.815 | −1.168 | 0.411 | −0.307 | −1.089 | |
| Adjusted Patell Z p-value | 0.566 | 0.415 | 0.243 | 0.681 | 0.759 | 0.276 | |
| IN (N = 27) AAR | −0.7% | 0.5% | −4.1% | 2.4% | 0.1% | −1.9% | |
| Adjusted Patell Z | −0.504 | 1.027 | −1.077 | 0.777 | −0.342 | −1.145 | |
| Adjusted Patell Z p-value | 0.614 | 0.305 | 0.282 | 0.437 | 0.732 | 0.252 | |
| OUTSIDE (N = 5) AAR | −0.2% | −0.6% | −1.2% | −3.1% | 0.5% | −1.8% | |
| Adjusted Patell Z | −0.274 | −0.315 | −0.441 | −0.743 | 0.018 | −0.091 | |
| Adjusted Patell Z p-value | 0.784 | 0.753 | 0.659 | 0.457 | 0.986 | 0.928 | |
| 3 | ALL (N = 30) AAR | 0.8% | 5.2% | −0.6% | 2.9% | −2.7% | 3.8% |
| Adjusted Patell Z | 1.209 | 2.861 | 1.272 | 0.882 | −1.553 | 2.290 | |
| Adjusted Patell Z p-value | 0.227 | 0.004*** | 0.203 | 0.378 | 0.120 | 0.022** | |
| IN (N = 17) AAR | −0.8% | 9.6% | −3.0% | 2.8% | −3.0% | 4.5% | |
| Adjusted Patell Z | 0.247 | 3.905 | −0.226 | −0.247 | −0.054 | 0.428 | |
| Adjusted Patell Z p–value | 0.805 | 0.000*** | 0.821 | 0.805 | 0.957 | 0.669 | |
| OUTSIDE (N = 13) AAR | 2.8% | −0.5% | 2.6% | 3.1% | −2.2% | 2.9% | |
| Adjusted Patell Z | 1.552 | −0.173 | 2.195 | 1.628 | −2.299 | 2.986 | |
| Adjusted Patell Z p–value | 0.121 | 0.863 | 0.028** | 0.104 | 0.022** | 0.003*** |
Number of observations by three study groups
| Arrangements concluded (Event No. 1) | Arrangements approved by a court (Event No. 2) | Arrangements becoming final (Event No. 3) | |
|---|---|---|---|
| Population of the companies under study | 37 | 36 | 32 |
| Final study sample | 32 | 32 | 30 |
Bankruptcies and restructurings in Poland in 2005–2021
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bankruptcy (liquidation) proceedings (business activities) | 793 | 576 | 377 | 348 | 572 | 538 | 616 | 711 | 703 | 701 | 650 | 530 | 537 | 558 | 574 | 507 | 373 |
| Bankruptcy proceedings with the possibility to make an arrangement (in accordance with the Bankruptcy and Reorganisation Act of 28 February 2003) | n/a | n/a | 70 | 63 | 119 | 117 | 107 | 166 | 180 | 122 | 91 | 26 | - | - | - | - | - |
| Restructuring proceedings (in force under the Restructuring Act of 15 May 2015) | - | - | - | - | - | - | - | - | - | - | - | 204 | 348 | 417 | 445 | 380 | 562 |
| Simplified restructuring proceedings (out of court, in force until November 30, 2021) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 356 | 1190 |
Event analysis results, including CAAR rates
| Event No. | Grouping variable | CAAR value | Pos:neg CAAR | Adjusted Patell Z | Adjusted Patell Z p-value | Statistical significance |
|---|---|---|---|---|---|---|
| 1 | ALL (N = 32) | −3.4% | 11:21 | −1.392 | 0.164 | |
| IN (N = 24) | −0.2% | 11:13 | −0.426 | 0.670 | ||
| OUTSIDE (N = 8) | −13.0% | 0:8 | −2.005 | 0.045 | ** | |
| 2 | ALL (N = 32) | −4.2% | 12:20 | −0.742 | 0.458 | |
| IN (N = 27) | −3.8% | 11:16 | −0.532 | 0.595 | ||
| OUTSIDE (N = 5) | −6.3% | 1:4 | −0.714 | 0.475 | ||
| 3 | ALL | 9.5% | 19:11 | 2.681 | 0.007 | *** |
| IN (N = 17) | 10.1% | 11:6 | 1.618 | 0.106 | ||
| OUTSIDE (N = 13) | 8.8% | 8:5 | 2.403 | 0.016 | ** |